PASI 75

Osaka, Japan & Cambridge, Mass., July 16, 2026 Takeda announced new Phase 3 data demonstrating that its investigational oral...

RAMAT GAN, Israel, July 6, 2026 Can-Fite BioPharma announced the completion of enrollment of the first 247 patients in...